Here are three things to know about Mr. Lingerfelt.
1. He is expected to begin his position in November.
2. He succeeds Flo Spyrow, who has been the interim CEO since January, when Brad Solberg resigned as CEO.
3. In information released from the hospital, Mr. Lingerfelt is quoted as saying, “I was attracted to HHH due to its strong track record, empowering values and outstanding employees, physicians and volunteers,” according to the report.
More articles on healthcare executive moves:
Arkansas interim CEO resigns over physician controversy: 4 things to know
SLU working toward succession plan for medical school dean, names Dr. Robert Heaney CEO of physician group
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
